Analysis of somatostatin receptor subtype mRNA expression in human breast cancer
1997

Somatostatin Receptor Expression in Breast Cancer

Sample size: 51 publication Evidence: moderate

Author Information

Author(s): AA Evans, T Crook, SAM Laws, AC Gough, GT RoyIe, JN Primrose

Primary Institution: Academic Department of Surgery, Southampton General Hospital

Hypothesis

The study investigates the expression of somatostatin receptor subtypes in human breast cancer tissue.

Conclusion

SSTR2 is ubiquitously expressed in breast cancer, while SSTR5 is expressed in about one-third of tumors, suggesting potential therapeutic applications for somatostatin analogues.

Supporting Evidence

  • SSTR2 was expressed in 98% of breast tumors analyzed.
  • Approximately one-third of tumors expressed SSTR5.
  • Only one tumor out of 51 was SSTR2 negative on RT-PCR.

Takeaway

This study looked at how certain receptors related to somatostatin are found in breast cancer tissues, which could help in treating the disease.

Methodology

The expression of somatostatin receptor subtypes was analyzed using reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization (ISH).

Limitations

The detection of mRNA does not necessarily imply the presence of functional cell-surface receptors.

Participant Demographics

77.5% of women were post-menopausal, with a mean age of 60 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication